Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Venus Remedies Limited ( (IN:VENUSREM) ) has issued an update.
Venus Remedies Limited has announced that, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, its trading window for dealing in the company’s securities will be closed for all designated persons from January 1, 2026 until 48 hours after the declaration of its audited financial results for the period ending December 31, 2025. The move is a routine compliance step aimed at preventing insider trading around the release of key financial information, reinforcing the company’s adherence to regulatory standards and safeguarding transparency for investors and other market participants.
More about Venus Remedies Limited
Venus Remedies Limited is an Indian pharmaceutical company engaged in manufacturing and marketing pharmaceutical products, with operations spanning multiple industrial units in Haryana and an overseas subsidiary, Venus Pharma GmbH in Germany. The company focuses on supplying medicines and related healthcare solutions to domestic and international markets.
Average Trading Volume: 7,959
Technical Sentiment Signal: Buy
Current Market Cap: 10.32B INR
Learn more about VENUSREM stock on TipRanks’ Stock Analysis page.